Please login to the form below
STDs
This page shows the latest STDs news and features for those working in and with pharma, biotech and healthcare.
Sexual health apps fail to attract smartphone users
HIV and STD apps not fulfilling their potential to assist with prevention and care. ... Among these, 71 per cent provided disease information about HIV/STDs, 36 per cent provided HIV/STD testing information or resources, 29 per cent included
Latest news
-
FDA cracks down on bogus STD drugs
The US Food and Drug Administration is partnering with the US Federal Trade Commission on an effort to get unapproved products for sexually transmitted diseases (STDs) off the market. ... The two federal agencies are targeting products that make unproven
-
Talent fish or flounder
It was a hypnotic that did it. I'd been "carrying the bag" up and down the Black Country for years, stuffed with NSAIDs, steroids and antibiotic drugs for STDs, bronchitis
-
Pfizer's 'Viva Viagra' TV ads come under fire
The Aids Healthcare Foundation (AHF) has criticised US pharmaceutical company Pfizer for excluding a caution against sexually transmitted diseases (STDs) and HIV from its verbal medical risk warnings in the latest ... Pfizer has also buried important STD
-
'Unscientific' HIV abstinence programmes continue in US
There are no programmes which currently meet this standard. At most, abstinence programmes have been found to reduce teens' sexual activity for a year or two, without an effect on STD
-
Lost in translation?
The nasty little English STD you picked up may be a MST in France or a German geschlechtskrankheit.
More from news
Approximately 1 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- FDA external report recommends actions to address US opioid crisis
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- The increasing value of rare disease trials
- Wrapping up EAU with a Look at Medscape’s Urology Impact
- MHRA to introduce new UK clinical trials framework
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Congress is in session – how companies are boosting their impact and engagement
- AstraZeneca announces major expansion of Canadian research footprint
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
PMHub
Say Communications
We focus on what matters most…. Driven by insight, expertise and fresh thinking, our award-winning communications programmes are designed to...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
